Madrid, Spain

Julio Alberto Reyes Rodriguez


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Julio Alberto Reyes Rodriguez

Introduction

Julio Alberto Reyes Rodriguez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes involved in various diseases. With a total of 3 patents, his work is paving the way for new therapeutic options.

Latest Patents

One of his latest patents focuses on heterocyclic GSK-3 allosteric modulators. This invention relates to heterocyclic substituted quinoline derivatives that act as allosteric inhibitors of the glycogen synthase kinase-3 (GSK-3) enzyme. These compounds are designed for the manufacturing of a medicament aimed at treating and preventing diseases where GSK-3 is implicated, such as neurodegenerative diseases, inflammatory diseases, cancer, and diabetes. Additionally, they promote various regenerative processes.

Career Highlights

Julio is affiliated with the Consejo Superior de Investigaciones Científicas, a prominent research institution in Spain. His work there has allowed him to explore innovative solutions to complex health issues. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Ana Martinez Gil and Carmen Gil Ayuso-Gontan. These partnerships have enhanced his research efforts and contributed to the advancement of his projects.

Conclusion

Julio Alberto Reyes Rodriguez is a distinguished inventor whose work in medicinal chemistry is making a significant impact. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…